Progressive Care, Inc.
RXMD · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.08 | -0.01 | 0.00 | 0.00 |
| FCF Yield | 0.52% | 2.50% | -1,209.06% | 610.47% |
| EV / EBITDA | 8.96 | -8.14 | -5.73 | -13.46 |
| Quality | ||||
| ROIC | -0.33% | -4.63% | 126.90% | -40.83% |
| Gross Margin | 30.49% | 23.90% | 26.19% | 23.03% |
| Cash Conversion Ratio | -0.05 | -0.10 | -3.48 | -0.79 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.57% | 1.40% | 5.99% | 22.98% |
| Free Cash Flow Growth | -78.46% | 153.73% | -283.73% | 173.71% |
| Safety | ||||
| Net Debt / EBITDA | -4.22 | 2.00 | -5.57 | -12.98 |
| Interest Coverage | 0.00 | -0.63 | -0.74 | -0.60 |
| Efficiency | ||||
| Inventory Turnover | 11.26 | 43.32 | 24.93 | 31.71 |
| Cash Conversion Cycle | -11.69 | -17.30 | -20.75 | -23.72 |